E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/20/2010 in the Prospect News High Yield Daily.

New Issue: Vanguard Health downsizes to $950 million, prices 8% eight-year notes at 98.555 to yield 8¼%

By Paul A. Harris

St. Louis, Jan. 20 - Vanguard Health Holding Co. II, LLC and Vanguard Holding Co. II, Inc. moved up timing, and priced a downsized $950 million issue of 8% eight-year senior notes (B3/CCC+) at 98.555 to yield 8¼% on Wednesday, according to informed source.

The yield printed at the tight end of the 8% to 8¼% price talk. The amount was reduced from $1 billion.

Previous to Wednesday evening's pricing the deal had been expected to price on Thursday morning.

Bank of America Merrill Lynch, Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. and Morgan Stanley & Co. were joint bookrunners.

Proceeds will be used to fund a tender for the company's 9% senior subordinated notes due 2014 and 11¼% senior discount notes due 2015 and, together with cash on hand, to fund a dividend to Vanguard's existing stockholders.

The issuing entities are subsidiaries of Nashville, Tenn.-based Vanguard Health Systems, Inc., which owns and operates hospitals and provides related services.

Issuer:Vanguard Health Holding Co. II, LLC and Vanguard Holding Co. II, Inc.
Amount:$950 million (decreased from $1 billion)
Maturity:Feb.1, 2018
Securities:Senior notes
Bookrunners:Bank of America Merrill Lynch, Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. and Morgan Stanley & Co.
Coupon:8%
Price:98.555
Yield:8¼%
Spread:494 bps
Call protection:Make-whole at Treasuries plus 50 bps until Feb. 1, 2014, then callable at a premium
Equity clawback:For 35% at 108.0 until Feb. 1, 2013
Trade date:Jan. 20
Settlement date:Jan. 29
Ratings:Moody's: B3
Standard & Poor's: CCC+
Distribution:Rule 144A and Regulation S
Price talk:8% to 8¼%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.